Sleeping Aid Market
Sleeping Aid Market Study by Drugs and Devices for Insomnia, Sleep Deprivation, Narcolepsy, and Sleep Apnea from 2024 to 2034
Analysis of Sleeping Aid Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Sleeping Aid Market Outlook (2024 to 2034)
The global sleeping aid market size is projected to reach a valuation of US$ 48.04 billion by the end of 2034, up from US$ 29.88 billion in 2024. Worldwide revenue from the sales of sleeping aids has been projected to increase at 4.9% CAGR from 2024 to 2034.
Sleep disorders affect the sleep cycle or disturb restful sleep, which can lead to daytime tiredness and other symptoms. Persistent sleep disorders result in daytime fatigue despite getting at least seven hours of sleep the night before and a diminished or impaired capacity to engage in routine daytime activities. Insomnia, narcolepsy, restless legs syndrome, and sleep apnea are some of the common sleep disorders.
Lack of sleep can have negative effects on academic and professional performance, interpersonal interactions, thinking, mental health, and weight, and also lead to the onset of diabetes and heart disease. Sleep disorders can be treated with natural sleep remedies using natural or herbal sleeping tablets, and also with homeopathic sleep remedies.
Key Market Growth Drivers
- Production of sleeping aids is increasing in developing countries, thus driving sleeping aid market growth.
- Increasing elderly population and prevalence of obesity are contributing to a rise in sleep problems and fueling demand for sleeping aids.
- Global demand for sleeping aids is driven by the growing patient population with cardiovascular diseases, respiratory issues, and obstructive sleep apnea.
- Treatment options for sleep disturbances encompass psychotherapy, medications, supplements, and wakefulness-promoting pharmaceuticals.
- Sleep apnea devices such as continuous positive airway pressure (CPAP) devices are gaining popularity for treating sleep-related disorders.
- Key sleeping aid manufacturers are introducing a variety of pills, incorporating ingredients like chamomile, hops, L-theanine, and melatonin, to meet the increasing demand.
- Increased awareness of the benefits of adequate sleep is driving demand for sleeping aid products.
- Key sleeping aid market trends that manufacturers are capitalizing on include rising product approvals, government support for improved therapeutic approaches, and advancements in sleep apnea testing.
| Report Attributes | Details |
|---|---|
| Sleeping Aid Market Size (2024E) | US$ 29.88 Billion |
| Forecasted Market Value (2034F) | US$ 48.04 Billion |
| Global Market Growth Rate (2024 to 2034) | 4.9% CAGR |
| North America Market Share (2024E) | 38% |
| East Asia Market Value (2034F) | US$ 8.84 Billion |
| Sales of Sleeping Aid Drugs (2024E) | US$ 5.5 Billion |
| Insomnia Segment Market Value (2034F) | US$ 13.17 Billion |
| Hospitals Segment Market Value (2034F) | US$ 7.02 Billion |
| Key Companies Profiled | Pfizer Inc.; Koninklijke Philips N.V.; Merck & Co. Inc.; Fisher & Paykel Healthcare Limited; Compumedics Ltd.; Abecca Healthcare; Betterlifehealthcare Ltd.; Lifeline Corporation Pte Ltd.; Compumedics Ltd.; Teva Pharmaceutical Industries Ltd.; ResMed Inc.; Cadwell Industries, Inc.; Sanofi SA; GlaxoSmithKline Plc.; Hill-Rom Holdings, Inc.; Drive DeVilbiss Healthcare LLC; Natus Medical, Inc. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What are the Opportunities on Offer for Sleeping Aid Manufacturers?
“Increase in Prevalence of Sleep Disorders and Innovation in Healthcare”
Altered sleep patterns brought on by lifestyle changes, easier access to medical services, and an increase in demand for high-quality healthcare are all factors generating opportunities for sleeping aid manufacturers. Several opportunities are opening up for suppliers of sleeping aid devices to address chronic sleep problems and enhance their market share.
Some other factors contributing to the increase in the sleeping aid market size include a focus on the expansion of healthcare infrastructure, widespread use of portable sleep apnea treatment equipment, rising geriatric population, increasing adoption of wearable sensors and monitors, and the pervasive burden of obstructive sleep apnea (OSA) and insomnia.
- May 2019 saw the successful completion of a phase-3 trial for insomnia treatment in patients with mild-to-moderate Alzheimer's disease and dementia using Merck's BELSOMRA (suvorexant) C-IV.
“Rising Awareness of Importance of Quality Sleep for Mental and Physical Well-being”
High quality of life and optimal physical and mental health depend on sufficient sleep. In today's 24/7 culture, inadequate sleep is a common issue with significant negative implications for health. Studies highlight the link between sleep deprivation and both physical and mental well-being.
Insufficient sleep is linked to workplace errors and car accidents, resulting in several injuries and disabilities annually. Adequate sleep is vital for maintaining overall health. Sleep problems elevate an individual's risk of health issues. Consequently, the demand for sleeping aids is on the rise.
Which Factors are Affecting Sales Growth of Sleeping Aids?
“Risk of Side Effects from Sleeping Aids and Wide Availability of Alternative Treatments”
Concerns about the complexity of treating sleep problems are growing with the introduction of new technologies. Furthermore, inadequate equipment standards for sleeping aid machines and insufficient documentation for the use and licensing of sleeping tablets are slowing down market growth. Common adverse reactions to sleeping aids include headaches, prolonged drowsiness, memory and performance issues during the day, and allergic reactions. The availability of alternative medications and treatments like circadian rhythm sleep therapy for conditions like narcolepsy and insomnia presents are also impediments to market growth.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Insights
North America accounts for a sizeable share of the global market for sleeping aids due to the focus of important industry players on innovation as well as rising consumer awareness about sleep quality and sleeping aid products. The market in East Asia is projected to expand at an impressive CAGR of 7.1% through 2034.
Why is the United States a Lucrative Market for Sleeping Aid Producers?
“Growing Awareness of Benefits of Sleeping Aid Products”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 9.62 Billion |
| Growth Rate (2024 to 2034) | 4.2% CAGR |
| Projected Value (2034F) | US$ 14.46 Billion |
The need for relevant sleeping aids is increasing as sleep disorders are becoming more common in the United States. The country is estimated to hold 84.7% sleeping aid market share in North America in 2024. Rising awareness of the benefits of sleeping aids is also contributing to their extensive adoption. The presence of some important market participants such as Merck and Pfizer in the nation is contributing to revenue growth.
Which Trends in China are Sleeping Aid Manufacturers Exploiting?
“Rising Prevalence of Insomnia among Younger Generation”
| Attribute | China |
|---|---|
| Market Value (2024E) | US$ 1.8 Billion |
| Growth Rate (2024 to 2034) | 7% CAGR |
| Projected Value (2034F) | US$ 3.6 Billion |
The healthcare sector in China is exhibiting significant growth due to several factors such as the increasing number of hospitals equipped with modern facilities, advancements in sleeping aid technology, and the rising prevalence of insomnia among the younger demographic. Lifestyle changes are also playing a pivotal role in driving market expansion. The increasing elderly and obese population in China is projected to boost the demand for sleeping drugs and gadgets.
Category-wise Insights
By product type, revenue from the sales of sleeping aid drugs is estimated at US$ 5.51 billion in 2024. Demand for sleeping aid products for the treatment of insomnia patients is estimated to expand at a 4.8% CAGR from 2024 to 2034
Which Condition Accounts for High Use of Sleeping Aids?
“Increased Demand for Sleeping Aids in Management of Sleep Apnea”
| Attribute | Sleep Apnea |
|---|---|
| Segment Value (2024E) | US$ 8.91 Billion |
| Growth Rate (2024 to 2034) | 5.1% CAGR |
| Projected Value (2034F) | US$ 14.69 Billion |
Sleep apnea is a sleep disorder characterized by irregular breathing patterns during sleep. Chronic sleep apnea results in insufficient oxygen supply to the brain and other organs, leading to irregular breathing during sleep. Elderly individuals and those with conditions like hypertension, diabetes, and cardiovascular disorders are more prone to such conditions. Obstructive sleep apnea is the most prevalent type globally, and it necessitates early detection and treatment with sleeping aid products like drugs and devices.
What are the Advantages Offered by e-Commerce for Sleeping Aid Product Distribution?
“Enhanced Accessibility to Product Information and Discount Offerings”
| Attribute | e-Commerce |
|---|---|
| Segment Value (2024E) | US$ 6.37 Billion |
| Growth Rate (2024 to 2034) | 5.1% CAGR |
| Projected Value (2034F) | US$ 10.44 Billion |
By distribution channel, e-commerce is expected to account for 21.3% of the global market share in 2024. Through e-commerce platforms, consumers obtain all the information related to a product with its advantages and disadvantages. Also, it is an easy, comfortable, and more convenient option to purchase sleeping aids. Additionally, some e-commerce platforms offer discounts on sleeping aid products, and this reason is making it a preferred choice for budget-conscious consumers. e-Commerce platforms are also helping consumers share their personal information and giving them access to useful information.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
Key players in the sleeping aid market include Pfizer Inc., Koninklijke Philips N.V., Merck & Co. Inc., Fisher & Paykel Healthcare Limited, Compumedics Ltd., Abecca Healthcare, Betterlifehealthcare Ltd., Lifeline Corporation Pte Ltd, Compumedics Ltd., and Teva Pharmaceutical Industries Ltd.
- In April 2024, Hostage Tape, a top sleeping aid manufacturer, and UFC, the top mixed martial arts organization in the world, announced a marketing agreement aimed at promoting the Hostage Tape brand across key assets of UFC.
- According to CNN Health, in April 2023, a study discovered that some of the over two dozen melatonin gummies marketed as sleeping aids in the United States had potentially harmful levels of the hormone that aids in sleep regulation.
Segmentation of Sleeping Aid Market Research
-
By Product :
- Drugs
- Insomnia Treatment Drugs
- Doxepin Hydrochloride
- Eszopiclone
- Ramelteon
- Triazolam
- Zaleplon
- Quazepam
- Narcolepsy Treatment Drugs
- Modafinil
- Sodium Oxybate
- Armodafinil
- Insomnia Treatment Drugs
- Devices
- CPAP Devices
- BiPAP Devices
- APAP Devices
- Others
- Mattresses & Pillows
- Chin Straps
- Mouth Pieces & Nasal Devices
- Drugs
-
By Indication :
- Insomnia
- Sleep Deprivation
- Narcolepsy
- Sleep Apnea
-
By Distribution Channel :
- Hospital Pharmacies
- Retail Pharmacies
- e-Commerce
- Drug Stores
-
By Region :
- North America
- Europe
- Latin America
- East Asia
- South Asia & Oceania
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Key Market Trends
- 4. Key Success Factors
- 5. Market Background
- 7. Global Market Volume (Units) Analysis 2018 to 2023 and Forecast, 2024 to 2034
- 8. Global Market - Pricing Analysis
- 9. Global Market Value Analysis 2018 to 2023 and Forecast, 2024 to 2034
- 10. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Product
- 10.1. Sleep Apnea Devices
- 10.2. Medication
- 10.3. Mattresses & Pillows
- 10.4. Sleep Laboratory Services
- 11. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Sleep Disorder
- 11.1. Insomnia
- 11.2. Sleep Apnea
- 11.3. Restless Leg Syndrome
- 11.4. Narcolepsy
- 11.5. Sleepwalking
- 11.6. Others
- 12. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Region
- 12.1. North America
- 12.2. Latin America
- 12.3. Europe
- 12.4. East Asia
- 12.5. South Asia
- 12.6. Oceania
- 12.7. Middle East and Africa (MEA)
- 13. North America Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 14. Latin America Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 15. Europe Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 16. South Asia Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 17. East Asia Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 18. Oceania Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 19. Middle East and Africa Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 20. Key and Emerging Countries Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 21. Market Structure Analysis
- 22. Competition Analysis
- 22.1. Abecca Healthcare
- 22.2. Becton, Dickinson and Company
- 22.3. Betterlifehealthcare Ltd.
- 22.4. Cadwell Industries, Inc.
- 22.5. Compumedics Ltd.
- 22.6. GlaxoSmithKline, Inc.
- 22.7. Hill-Rom Holdings, Inc.
- 22.8. Koninklijke Philips NV
- 22.9. Lifeline Corporation Pte Ltd
- 22.10. Merck & Co., Inc.
- 22.11. Natus Medical, Inc.
- 22.12. Pfizer, Inc.
- 22.13. Teva Pharmaceutical Industries Ltd.
- 23. Assumptions and Acronyms Used
- 24. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Volume (‘000 Units) Analysis and Opportunity Assessment 2018 to 2034, By Product
Table 02: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product
Table 03: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Sleep Disorder
Table 04: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Region
Table 05: North America Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 06: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product
Table 07: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Sleep Disorder
Table 08: Latin America Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 09: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product
Table 10: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Sleep Disorder
Table 11: Europe Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 12: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product
Table 13: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Sleep Disorder
Table 14: South Asia Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 15: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product
Table 16: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Sleep Disorder
Table 17: East Asia Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 18: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product
Table 19: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Sleep Disorder
Table 20: Oceania Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 21: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product
Table 22: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Sleep Disorder
Table 23: Middle East and Africa Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 24: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product
Table 25: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Sleep Disorder
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Volume (in 000' Units) Analysis, 2018 to 2023
Figure 02: Global Market Volume Forecast (in 000' Units), 2024 to 2034
Figure 03: Pricing Analysis (US$) Per Product, By Region, 2023
Figure 04: Pricing Analysis (US$) Per Product, By Region, 2023
Figure 05: Global Market Value Analysis (US$ Mn), 2018 to 2023
Figure 06: Global Market Value Forecast (US$ Mn), 2024 to 2034
Figure 07: Global Market Absolute $ Opportunity, 2024 to 2034
Figure 08: Global Market Share Analysis (%), By Product, 2024 to 2034
Figure 09: Global Market Y-o-Y Analysis (%), By Product, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by Product, 2024 to 2034
Figure 11: Global Market Share Analysis (%), By Sleep Disorder, 2024 to 2034
Figure 12: Global Market Y-o-Y Analysis (%), By Sleep Disorder, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by Sleep Disorder, 2024 to 2034
Figure 14: Global Market Share Analysis (%), By Region, 2024 to 2034
Figure 15: Global Market Y-o-Y Analysis (%), By Region, 2024 to 2034
Figure 16: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 17: North America Market Value Share, By Product, 2024 (E)
Figure 18: North America Market Value Share, By Sleep Disorder, 2024 (E)
Figure 19: North America Market Value Share, By Country, 2024 (E)
Figure 20: North America Market Value Analysis (US$ Mn), 2018 to 2023
Figure 21: North America Market Value Forecast (US$ Mn), 2024 to 2034
Figure 22: North America Market Attractiveness Analysis by Product, 2024 to 2034
Figure 23: North America Market Attractiveness Analysis by Sleep Disorder, 2024 to 2034
Figure 24: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 25: Latin America Market Value Share, By Product, 2024 (E)
Figure 26: Latin America Market Value Share, By Sleep Disorder, 2024 (E)
Figure 27: Latin America Market Value Share, By Country, 2024 (E)
Figure 28: Latin America Market Value Analysis (US$ Mn), 2018 to 2023
Figure 29: Latin America Market Value Forecast (US$ Mn), 2024 to 2034
Figure 30: Latin America Market Attractiveness Analysis by Product, 2024 to 2034
Figure 31: Latin America Market Attractiveness Analysis by Sleep Disorder, 2024 to 2034
Figure 32: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 33: Europe Market Value Share, By Product, 2024 (E)
Figure 34: Europe Market Value Share, By Sleep Disorder, 2024 (E)
Figure 35: Europe Market Value Share, By Country, 2024 (E)
Figure 36: Europe Market Value Analysis (US$ Mn), 2018 to 2023
Figure 37: Europe Market Value Forecast (US$ Mn), 2024 to 2034
Figure 38: Europe Market Attractiveness Analysis by Product, 2024 to 2034
Figure 39: Europe Market Attractiveness Analysis by Sleep Disorder, 2024 to 2034
Figure 40: Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 41: South Asia Market Value Share, By Product, 2024 (E)
Figure 42: South Asia Market Value Share, By Sleep Disorder, 2024 (E)
Figure 43: South Asia Market Value Share, By Country, 2024 (E)
Figure 44: South Asia Market Value Analysis (US$ Mn), 2018 to 2023
Figure 45: South Asia Market Value Forecast (US$ Mn), 2024 to 2034
Figure 46: South Asia Market Attractiveness Analysis by Product, 2024 to 2034
Figure 47: South Asia Market Attractiveness Analysis by Sleep Disorder, 2024 to 2034
Figure 48: South Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 49: East Asia Market Value Share, By Product, 2024 (E)
Figure 50: East Asia Market Value Share, By Sleep Disorder, 2024 (E)
Figure 51: East Asia Market Value Share, By Country, 2024 (E)
Figure 52: East Asia Market Value Analysis (US$ Mn), 2018 to 2023
Figure 53: East Asia Market Value Forecast (US$ Mn), 2024 to 2034
Figure 54: East Asia Market Attractiveness Analysis by Product, 2024 to 2034
Figure 55: East Asia Market Attractiveness Analysis by Sleep Disorder, 2024 to 2034
Figure 56: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 57: Oceania Market Value Share, By Product, 2024 (E)
Figure 58: Oceania Market Value Share, By Sleep Disorder, 2024 (E)
Figure 59: Oceania Market Value Share, By Country, 2024 (E)
Figure 60: Oceania Market Value Analysis (US$ Mn), 2018 to 2023
Figure 61: Oceania Market Value Forecast (US$ Mn), 2024 to 2034
Figure 62: Oceania Market Attractiveness Analysis by Product, 2024 to 2034
Figure 63: Oceania Market Attractiveness Analysis by Sleep Disorder, 2024 to 2034
Figure 64: Oceania Market Attractiveness Analysis by Country, 2024 to 2034
Figure 65: Middle East and Africa Market Value Share, By Product, 2024 (E)
Figure 66: Middle East and Africa Market Value Share, By Sleep Disorder, 2024 (E)
Figure 67: Middle East and Africa Market Value Share, By Country, 2024 (E)
Figure 68: Middle East and Africa Market Value Analysis (US$ Mn), 2018 to 2023
Figure 69: Middle East and Africa Market Value Forecast (US$ Mn), 2024 to 2034
Figure 70: Middle East and Africa Market Attractiveness Analysis by Product, 2024 to 2034
Figure 71: Middle East and Africa Market Attractiveness Analysis by Sleep Disorder, 2024 to 2034
Figure 72: Middle East and Africa Market Attractiveness Analysis by Country, 2024 to 2034
Figure 73: U. S. Market Value Analysis (US$ Mn), 2024 & 2034
Figure 74: U. S. Market Value Share, By Product, 2024 (E)
Figure 75: U. S. Market Value Share, By Sleep Disorder, 2024 (E)
Figure 76: Canada Market Value Analysis (US$ Mn), 2024 & 2034
Figure 77: Canada Market Value Share, By Product, 2024 (E)
Figure 78: Canada Market Value Share, By Sleep Disorder, 2024 (E)
Figure 79: Mexico Market Value Analysis (US$ Mn), 2024 & 2034
Figure 80: Mexico Market Value Share, By Product, 2024 (E)
Figure 81: Mexico Market Value Share, By Sleep Disorder, 2024 (E)
Figure 82: Brazil Market Value Analysis (US$ Mn), 2024 & 2034
Figure 83: Brazil Market Value Share, By Product, 2024 (E)
Figure 84: Brazil Market Value Share, By Sleep Disorder, 2024 (E)
Figure 85: U. K. Market Value Analysis (US$ Mn), 2024 & 2034
Figure 86: U. K. Market Value Share, By Product, 2024 (E)
Figure 87: U. K. Market Value Share, By Sleep Disorder, 2024 (E)
Figure 88: Germany Market Value Analysis (US$ Mn), 2024 & 2034
Figure 89: Germany Market Value Share, By Product, 2024 (E)
Figure 90: Germany Market Value Share, By Sleep Disorder, 2024 (E)
Figure 91: France Market Value Analysis (US$ Mn), 2024 & 2034
Figure 92: France Market Value Share, By Product, 2024 (E)
Figure 93: France Market Value Share, By Sleep Disorder, 2024 (E)
Figure 94: Italy Market Value Analysis (US$ Mn), 2024 & 2034
Figure 95: Italy Market Value Share, By Product, 2024 (E)
Figure 96: Italy Market Value Share, By Sleep Disorder, 2024 (E)
Figure 97: Spain Market Value Analysis (US$ Mn), 2024 & 2034
Figure 98: Spain Market Value Share, By Product, 2024 (E)
Figure 99: Spain Market Value Share, By Sleep Disorder, 2024 (E)
Figure 100: Russia Market Value Analysis (US$ Mn), 2024 & 2034
Figure 101: Russia Market Value Share, By Product, 2024 (E)
Figure 102: Russia Market Value Share, By Sleep Disorder, 2024 (E)
Figure 103: China Market Value Analysis (US$ Mn), 2024 & 2034
Figure 104: China Market Value Share, By Product, 2024 (E)
Figure 105: China Market Value Share, By Sleep Disorder, 2024 (E)
Figure 106: Japan Market Value Analysis (US$ Mn), 2024 & 2034
Figure 107: Japan Market Value Share, By Product, 2024 (E)
Figure 108: Japan Market Value Share, By Sleep Disorder, 2024 (E)
Figure 109: South Korea Market Value Analysis (US$ Mn), 2024 & 2034
Figure 110: South Korea Market Value Share, By Product, 2024 (E)
Figure 111: South Korea Market Value Share, By Sleep Disorder, 2024 (E)
Figure 112: India Market Value Analysis (US$ Mn), 2024 & 2034
Figure 113: India Market Value Share, By Product, 2024 (E)
Figure 114: India Market Value Share, By Sleep Disorder, 2024 (E)
Figure 115: ASEAN Market Value Analysis (US$ Mn), 2024 & 2034
Figure 116: ASEAN Market Value Share, By Product, 2024 (E)
Figure 117: ASEAN Market Value Share, By Sleep Disorder, 2024 (E)
Figure 118: Australia Market Value Analysis (US$ Mn), 2024 & 2034
Figure 119: Australia Market Value Share, By Product, 2024 (E)
Figure 120: Australia Market Value Share, By Sleep Disorder, 2024 (E)
Figure 121: New Zealand Market Value Analysis (US$ Mn), 2024 & 2034
Figure 122: New Zealand Market Value Share, By Product, 2024 (E)
Figure 123: New Zealand Market Value Share, By Sleep Disorder, 2024 (E)
Figure 124: GCC Countries Market Value Analysis (US$ Mn), 2024 & 2034
Figure 125: GCC Countries Market Value Share, By Product, 2024 (E)
Figure 126: GCC Countries Market Value Share, By Sleep Disorder, 2024 (E)
Figure 127: Turkey Market Value Analysis (US$ Mn), 2024 & 2034
Figure 128: Turkey Market Value Share, By Product, 2024 (E)
Figure 129: Turkey Market Value Share, By Sleep Disorder, 2024 (E)
Figure 130: South Africa Market Value Analysis (US$ Mn), 2024 & 2034
Figure 131: South Africa Market Value Share, By Product, 2024 (E)
Figure 132: South Africa Market Value Share, By Sleep Disorder, 2024 (E)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the sleeping aid market in 2024?
The global market for sleeping aids is estimated at US$ 29.88 billion in 2024.
At what rate is the demand for sleeping aids projected to rise?
Sales of sleeping aids are forecasted to increase at 4.9% CAGR through 2034.
What is the demand projection for the global market by 2034?
The market has been forecasted to reach US$ 48.04 billion by 2034-end.
Which product type holds a significant market share of sleeping aids?
Sleeping aid drugs are projected to occupy a market share of 18.4% in 2024.
At what rate is the market forecasted to expand in Japan?
The market in Japan is projected to expand at a CAGR of 7.1% through 2034.
Who are the leading manufacturers of sleeping aids?
Key producers of sleeping aid products include Pfizer Inc., Fisher & Paykel Healthcare Limited, and Abecca Healthcare.
Sleeping Aid Market